An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon

Phase 1/2 Terminated 13 enrolled Photocure

Non-randomizedSingle-groupOpen-labelDiagnostic

The purpose of the study is to determine if it is possible to detect more pre-cancerous lesions in colon when using fluorescence technology.

Outcome not reported

Stopped: “The study was stopped due to inadequate efficacy after 13 patients were evaluated.”

Evaluation	Drug	Modality	Dose	Route
Subject	hexaminolevulinate	Small molecule	200 mg	Oral